Summary
Johnson & Johnson (JNJ) filed an 8-K on April 19, 2016, primarily to report its first-quarter 2016 financial results. The filing includes a press release and supplementary financial data detailing sales and earnings for the quarter ended April 3, 2016. Investors should review this report for updates on the company's performance in the initial months of the year, which would typically influence expectations for the full fiscal year.
Key Highlights
- 1JNJ announced its first-quarter 2016 financial results on April 19, 2016.
- 2The filing specifically covers the financial performance for the quarter ended April 3, 2016.
- 3Key financial metrics such as sales and earnings were disclosed.
- 4The report includes a press release dated April 19, 2016, detailing the quarterly results.
- 5Unaudited comparative supplementary sales data and condensed consolidated statements of earnings are provided.
- 6This 8-K serves as the official notification of JNJ's Q1 2016 financial performance.
Frequently Asked Questions
The primary purpose of this 8-K filing is to officially announce and provide the details of Johnson & Johnson's financial results for the first quarter ended April 3, 2016. This includes reporting sales and earnings figures.
The detailed financial information, including sales and earnings, is contained within the press release dated April 19, 2016, and the accompanying unaudited comparative supplementary sales data and condensed consolidated statements of earnings, both filed as exhibits with this 8-K.
This report covers the first quarter of fiscal year 2016, which ended on April 3, 2016.
This filing is an actual performance report, detailing the company's sales and earnings for the completed first quarter of 2016.